Cargando…
MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges
Autores principales: | Krishnaswami, Sriram, Austin, Daren, Della Pasqua, Oscar, Gastonguay, Marc R., Gobburu, Jogarao, van der Graaf, Piet H., Ouellet, Daniele, Tannenbaum, Stacey, Visser, Sandra A. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7158219/ https://www.ncbi.nlm.nih.gov/pubmed/31955417 http://dx.doi.org/10.1002/cpt.1788 |
Ejemplares similares
-
Good Practices in Model‐Informed Drug Discovery and Development: Practice, Application, and Documentation
por: Marshall, SF, et al.
Publicado: (2016) -
No mission is impossible for LHCb
por: CERN Bulletin
Publicado: (2011) -
Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
por: Geerts, Hugo, et al.
Publicado: (2019) -
Quality assessment in surgery: mission impossible?
por: Dindo, Daniel, et al.
Publicado: (2010) -
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network
por: Cucurull‐Sanchez, Lourdes, et al.
Publicado: (2019)